102 related articles for article (PubMed ID: 7545055)
1. Biochemical and functional markers of lung damage after bleomycin treatment.
Villani F; Galimberti M; Barbieri A; Luisetti M; Bacchella L; Aprile C
Monaldi Arch Chest Dis; 1995 May; 50(3):183-6. PubMed ID: 7545055
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme: an indicator of bleomycin-induced pulmonary toxicity in humans?
Sørensen PG; Rømer FK; Cortes D
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1405-8. PubMed ID: 6209143
[TBL] [Abstract][Full Text] [Related]
3. Study of functional and biochemical indicators of subclinical lung damage in bleomycin-treated patients.
Villani F; Bacchella L; Bulgheroni A; Pizzini L; Galimberti M; Aprile C; Luisetti M
Respir Med; 1992 Jul; 86(4):327-33. PubMed ID: 1280368
[TBL] [Abstract][Full Text] [Related]
4. Natural course of bleomycin-induced pneumonitis. A follow-up study.
Van Barneveld PW; Sleijfer DT; van der Mark TW; Mulder NH; Koops HS; Sluiter HJ; Peset R
Am Rev Respir Dis; 1987 Jan; 135(1):48-51. PubMed ID: 2432813
[TBL] [Abstract][Full Text] [Related]
5. Bleomycin-induced changes in the carbon monoxide transfer factor of the lungs and its components.
Luursema PB; Star-Kroesen MA; van der Mark TW; Sleyfer DT; Koops HS; Peset R
Am Rev Respir Dis; 1983 Nov; 128(5):880-3. PubMed ID: 6195947
[TBL] [Abstract][Full Text] [Related]
6. [Study of biological markers of pulmonary fibrosis with clinical peplomycin or radiotherapy].
Nakata M; Honma T; Fukuda Y; Yoneda S; Noguchi Y; Yoshida S; Tari K; Kojima S; Takada K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):723-5. PubMed ID: 2451475
[No Abstract] [Full Text] [Related]
7. Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect.
Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
Br J Cancer; 1995 Jan; 71(1):120-3. PubMed ID: 7529523
[TBL] [Abstract][Full Text] [Related]
8. [Application of serum type III procollagen peptide level in the diagnosis of lung fibrosis developed during bleomycin treatment in cancer patients].
Okazaki I; Miura K; Ohya S; Murakami M; Nagata N; Maruyama K; Kobayashi T; Okuno F; Oda S; Ito H
Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2104-11. PubMed ID: 2419464
[No Abstract] [Full Text] [Related]
9. [Bleomycin-induced pneumonia].
Berger K; Göpfert A; Berkel H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Nov; 31(9):577-81. PubMed ID: 9063925
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin-induced nodular pulmonary fibrosis masquerading as metastatic testicular cancer.
Dineen MK; Englander LS; Huben RP
J Urol; 1986 Aug; 136(2):473-5. PubMed ID: 2426475
[TBL] [Abstract][Full Text] [Related]
11. Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?
Bokemeyer C
J Clin Oncol; 2008 Apr; 26(11):1783-5. PubMed ID: 18398143
[No Abstract] [Full Text] [Related]
12. [Serum type III procollagen peptide in diagnosis of lung fibrosis due to silicosis and bleomycin toxicity].
Okuno F; Maruyama K; Okazaki I; Arai M; Suzuki H
J UOEH; 1985 Sep; 7(3):291-7. PubMed ID: 2416026
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of pulmonary function in patients cured from testicular cancer with combination chemotherapy including bleomycin.
Lehne G; Johansen B; Fosså SD
Br J Cancer; 1993 Sep; 68(3):555-8. PubMed ID: 7688978
[TBL] [Abstract][Full Text] [Related]
14. Assessment of bleomycin lung toxicity using angiotensin-converting enzyme in pulmonary lavage.
Newman RA; Kimberly PJ; Stewart JA; Kelley J
Cancer Res; 1980 Oct; 40(10):3621-6. PubMed ID: 6159967
[TBL] [Abstract][Full Text] [Related]
15. Influence of platinum-induced renal toxicity on bleomycin-induced pulmonary toxicity in patients with disseminated testicular carcinoma.
van Barneveld PW; Sleijfer DT; van der Mark TW; Mulder NH; Donker AJ; Meijer S; Schraffordt Koops H; Sluiter HJ; Peset R
Oncology; 1984; 41(1):4-7. PubMed ID: 6199706
[TBL] [Abstract][Full Text] [Related]
16. [Serum type III procollagen peptide in diagnosis of lung fibrosis due to silicosis and bleomycin toxicity].
Okuno F; Maruyama K; Okazaki I; Arai M; Suzuki H
J UOEH; 1986 Mar; 8 Suppl():355-61. PubMed ID: 2425407
[TBL] [Abstract][Full Text] [Related]
17. Low toxicity with continuous infusion of high-dose bleomycin in poor prognostic testicular cancer.
Gerson R; Tellez Bernal E; Lazaro Leon M; Sanchez Forgach E; Garcia Irigoyen C; Gutierrez Godinez F; Garcia Gonzalez H
Am J Clin Oncol; 1993 Aug; 16(4):323-6. PubMed ID: 7687091
[TBL] [Abstract][Full Text] [Related]
18. Changes in pulmonary function during and after bleomycin treatment in patients with testicular carcinoma.
van Barneveld PW; Veenstra G; Sleijfer DT; van der Mark TW; Mulder NH; Schraffordt Koops H; Sluiter HJ; Peset R
Cancer Chemother Pharmacol; 1985; 14(2):168-71. PubMed ID: 2578898
[TBL] [Abstract][Full Text] [Related]
19. Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin.
Sleijfer S; van der Mark TW; Schraffordt Koops H; Mulder NH
Eur J Cancer; 1996 Mar; 32A(3):550-2. PubMed ID: 8814706
[TBL] [Abstract][Full Text] [Related]
20. [Probable pulmonary damage caused by bleomycin. Communication of 4 cases].
Arraztoa J; Oddó D; Cerda B; San Martin S
Rev Med Chil; 1991 Nov; 119(11):1270-6. PubMed ID: 9723079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
